A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
Explants from the midbrain dopamine system and striatum are used in a collagen matrix assay for the in vitro analysis of mesostriatal and striatonigral pathway development. In this assay axonal outgrowth and guidance can be manipulated and quantified. It can also be modified for assessing other regions or molecular cues.
Midbrain dopamine (mdDA) neurons project via the medial forebrain bundle towards several areas in the telencephalon, including the striatum1. Reciprocally, medium spiny neurons in the striatum that give rise to the striatonigral (direct) pathway innervate the substantia nigra2. The development of these axon tracts is dependent upon the combinatorial actions of a plethora of axon growth and guidance cues including molecules that are released by neurites or by (intermediate) target regions3,4. These soluble factors can be studied in vitro by culturing mdDA and/or striatal explants in a collagen matrix which provides a three-dimensional substrate for the axons mimicking the extracellular environment. In addition, the collagen matrix allows for the formation of relatively stable gradients of proteins released by other explants or cells placed in the vicinity (e.g. see references 5 and 6). Here we describe methods for the purification of rat tail collagen, microdissection of dopaminergic and striatal explants, their culture in collagen gels and subsequent immunohistochemical and quantitative analysis. First, the brains of E14.5 mouse embryos are isolated and dopaminergic and striatal explants are microdissected. These explants are then (co)cultured in collagen gels on coverslips for 48 to 72 hours in vitro. Subsequently, axonal projections are visualized using neuronal markers (e.g. tyrosine hydroxylase, DARPP32, or βIII tubulin) and axon growth and attractive or repulsive axon responses are quantified. This neuronal preparation is a useful tool for in vitro studies of the cellular and molecular mechanisms of mesostriatal and striatonigral axon growth and guidance during development. Using this assay, it is also possible to assess other (intermediate) targets for dopaminergic and striatal axons or to test specific molecular cues.
1. Preparation of Rat Tail Collagen
Dissection of rat tails (in tissue culture hood):
(keep tools in 70% ethanol when not using them and make sure that all solutions, tools and glassware used throughout this procedure are sterile)
2. Dissection of the Dopaminergic Midbrain7,8
All subsequent dissection steps are performed in L15 medium on ice.
3. Dissection of the Striatum
All dissection steps are performed in L15 medium on ice.
4. Assembly Collagen Matrix Assays
Preparation of the collagen (all steps on ice, use cooled pipette tips)
Setup co-culture in collagen gel
5. Analysis by Immunohistochemistry and Quantification
Immunohistochemistry
Quantification by calculating P/D ratio
6. Representative Images
After successful culture of dopaminergic and striatal explants a large number of axons are visible using bright field microscopy or as visualized by anti-βIII tubulin immunocytochemistry (not shown). A subset of these axons will be dopaminergic or striatal axons as visualized using immunocytochemistry (Figure 3). By dividing the explants into quadrants as described and determining P/D ratios, a putative axon attractive or repulsive effect can be quantified (Figure 3E).
Figure 1. Photos illustrating the preparation of collagen from rat tail tendons. A) Pulling apart the rat tail exposes the tendons. B) Tendons are visible as rope-like bundles. C) The tendons are easy to distinguish from veins by their shiny white appearance. D) After dissolving the tendons in acetic acid, the solution is transferred to dialysis tubing. To keep the dissolved collagen cold, tubes are placed on sterile aluminum foil on ice.
Figure 2. Schematic indicating the different steps of the procedure. Appropriate brain regions are dissected and cut to generate explants. A single midbrain and striatal explant are positioned in close proximity in a collagen matrix and left to grow for 48-72 hours at 37 °C. Axons are visualized by fluorescence immunohistochemistry and a P/D ratio is calculated to quantify chemotropic responses.
Figure 3. Representative results showing axon growth in a collagen matrix culture. A) Midbrain explant stained with anti-tyrosine hydroxylase antibody revealing axon outgrowth. Dotted line indicates adjacent explant. B) Magnification of A showing individual neurites and growth cones (arrows). C) Striatal explant stained with anti-DARPP32. D) Magnification of C showing individual neurites. E) Example of P/D ratio quantification. Explants are divided into equal quadrants. The proximal quadrant is facing the adjacent explant while the distal quadrant is facing away from it. Scale bars indicate 100 μm.
The collagen matrix assay described here has been used and improved by many different labs in the past decades to investigate a variety of axon guidance molecules and neuronal systems (e.g. see references 5-8). These studies have shown that this assay is a powerful tool for studying the effects and regulation of axon guidance molecules secreted by different (intermediate) target tissues.
However, it should be noted that the collagen matrix is a substitute for the extracellular environment (EC...
We have nothing to disclose.
The collagen matrix assay has been developed and improved by the work of many different research groups during the past two to three decades. The approaches described here for dopaminergic and striatal explants greatly benefit from these studies. In addition, the authors would like to thank Asheeta Prasad for her help in setting up striatal explant cultures. Work in the lab was funded by the Human frontier Science Program Organization (Career Development Award), the Netherlands Organization of Health Research and Development (ZonMW-VIDI and ZonMW-TOP), the Europanian Union (mdDA-NeuroDev, FP7/2007-2011, Grant 222999) (to RJP), and the Netherlands Organization for Scientific Research (TopTalent; to ERES).
Name | Company | Catalog Number | Comments |
Fetal Calf Serum | BioWhittaker | 14-801F | |
Glutamine (200mM) | PAA Laboratories | M11-004 | |
Hepes | VWR international | 441476L | |
β-Mercapt–thanol | Merck & Co., Inc. | 444203 | |
Minimum Essential Media (MEM) | GIBCO, by Life Technologies | 61100-087 | |
Neurobasal | GIBCO, by Life Technologies | 21103-049 | |
B27 | GIBCO, by Life Technologies | 17504-044 | |
Leibovitz’s L-15 Medium | GIBCO, by Life Technologies | 11415-049 | |
Penicillin-Streptomycin | GIBCO, by Life Technologies | 15070-063 | |
Prolong Gold Antifade Reagent | Invitrogen | P36930 | |
Dialysis tubing | Spectrum Labs | 132660 | |
Rabbit anti-Tyrosine Hydroxylase | Pel-Freez Biologicals | P40101-0 | |
Rabbit anti-Darpp32 (H-62) | Santa Cruz Biotechnology, Inc. | Sc-11365 | |
Mouse anti-βIII tubulin | Sigma-Aldrich | T8660 | |
Alexa Fluor labeled secondary antibodies | Invitrogen |
Request permission to reuse the text or figures of this JoVE article
Request PermissionThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. All rights reserved